AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $786,017 | -8.3% | 62,581 | -19.1% | 0.36% | -48.4% |
| Q1 2023 | $857,412 | -9.2% | 77,314 | 0.0% | 0.70% | +24.6% |
| Q4 2022 | $944,004 | +31.3% | 77,314 | +12.3% | 0.56% | +36.3% |
| Q3 2022 | $719,000 | -25.8% | 68,830 | -23.7% | 0.41% | -29.7% |
| Q2 2022 | $969,000 | -5.5% | 90,234 | -16.6% | 0.58% | -10.3% |
| Q1 2022 | $1,025,000 | -21.8% | 108,257 | -4.5% | 0.65% | -37.5% |
| Q4 2021 | $1,310,000 | +21.0% | 113,387 | 0.0% | 1.04% | +45.5% |
| Q3 2021 | $1,083,000 | +33.2% | 113,387 | +34.4% | 0.72% | +24.3% |
| Q2 2021 | $813,000 | -11.4% | 84,371 | +112.1% | 0.58% | -1.5% |
| Q4 2020 | $918,000 | +97.8% | 39,774 | +20.9% | 0.59% | +73.4% |
| Q3 2020 | $464,000 | +14.6% | 32,893 | +22.4% | 0.34% | +0.9% |
| Q2 2020 | $405,000 | – | 26,863 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |